After a $3.3 bn acquisition, is it finally time to look at Biocon? Biocon’s growth story has long been muted — until now. With Viatris in its fold and a strong biosimilars pipeline, the company is ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett’s oesophagus, a known precursor to esophageal cancer, according to a new study ...

The plan outlines the technical, physical, and regulatory steps needed to safely permanently close all tanks at the Red Hill structure.